Repligen Corp
NASDAQ:RGEN
Repligen Corp
EPS (Diluted)
Repligen Corp
EPS (Diluted) Peer Comparison
Competitive EPS (Diluted) Analysis
Latest Figures & CAGR of Competitors
Company | EPS (Diluted) | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Repligen Corp
NASDAQ:RGEN
|
EPS (Diluted)
$0
|
CAGR 3-Years
-44%
|
CAGR 5-Years
-11%
|
CAGR 10-Years
-8%
|
|
Thermo Fisher Scientific Inc
NYSE:TMO
|
EPS (Diluted)
$15
|
CAGR 3-Years
-1%
|
CAGR 5-Years
16%
|
CAGR 10-Years
16%
|
|
Danaher Corp
NYSE:DHR
|
EPS (Diluted)
$10
|
CAGR 3-Years
20%
|
CAGR 5-Years
26%
|
CAGR 10-Years
12%
|
|
Mettler-Toledo International Inc
NYSE:MTD
|
EPS (Diluted)
$36
|
CAGR 3-Years
9%
|
CAGR 5-Years
11%
|
CAGR 10-Years
13%
|
|
Agilent Technologies Inc
NYSE:A
|
EPS (Diluted)
$4
|
CAGR 3-Years
17%
|
CAGR 5-Years
3%
|
CAGR 10-Years
7%
|
|
IQVIA Holdings Inc
NYSE:IQV
|
EPS (Diluted)
$7
|
CAGR 3-Years
72%
|
CAGR 5-Years
43%
|
CAGR 10-Years
16%
|
See Also
What is Repligen Corp's EPS (Diluted)?
EPS (Diluted)
0.3
USD
Based on the financial report for Mar 31, 2024, Repligen Corp's EPS (Diluted) amounts to 0.3 USD.
What is Repligen Corp's EPS (Diluted) growth rate?
EPS (Diluted) CAGR 10Y
-8%
Over the last year, the EPS (Diluted) growth was -92%. The average annual EPS (Diluted) growth rates for Repligen Corp have been -44% over the past three years , -11% over the past five years , and -8% over the past ten years .